South Korean Stocks Had a Breakout 2025. Can It Continue?

How Western Digital Became the S&P 500’s Best Stock in 2025—and Why Trade Desk Was the Worst

These Stocks Moved the Most Today: Nvidia, Tesla, Nike, DJT, Hecla, Newmont, Corcept, Vanda, and More

Tesla Closes Year on Six-Day Losing Streak. Next Up, EV Deliveries.

10 People to Watch in Wealth Management in 2026

In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s

Robo-Taxis and Home Runs? 40 ’Forgotten’ Stocks for 2026.

Cathie Wood’s ARK Funds Have Crushed the Market This Year. What’s She’s Buying Now.

Gambling Problem? There’s an App for That.

The 5 Best Stocks to Play AI in 2026, According to Wall Street’s Loudest Tech Bull

Dogs of the Dow Had a Strong Year. Here Are the 10 Stocks for 2026.

Remember DeepSeek? China Could Have a New Nvidia Threat.

DJT Stock Jumps. Shareholders Will Get a Digital ‘Dividend.’

Alphabet Stock Can Rise Another 22%, Analyst Says. Here’s Why.

Warren Buffett’s Likely Replacement as Berkshire’s Top Stock Picker Has a Lot to Prove

3 Stocks Set to Benefit as Elon Musk’s xAI Expands Its Huge Data Center

Investing Regrets? A Guide to Costanza-Method Stockpicking.

Charles Schwab Is Back on Offense. Its Stock Is a Buy.

Caterpillar Stock Is an Unlikely AI Play as Data Center Power Demand Surges

Experts Share Their Wealth Management Predictions for 2026

Trump Accounts Are Coming in 2026. What It Means for You.

Corcept Therapeutics Shares Plunge 50% After FDA Rejects Blood Pressure Drug

Mortgage Rates End 2025 at a Yearly Low, Signaling Relief for 2026 Buyers

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval

Nvidia Stock Has Barely Budged Since the End of July. What Gets It Going Again.